In contrast, a recent study reported that 20% of MM post SRS had a temporary, reversible increase in size much earlier at 3–6 months after concomitant treatment with anti-PD-1 ICI, compared to 5% with radiosurgery alone [28]. Here, PDCD1 is linked to Miyoshi myopathy.